Deciphering cancer heterogeneity: The biological space

Frontiers in Cell and Developmental Biology

Volumn 2, Issue APR, 2014, Pages

  Roessler, Stephanie ^a,b   Budhu, Anuradha ^a   Wang, Xin W ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Cancer drivers; Cancer genomic heterogeneity; Gene signatures; Hepatocellular carcinoma; Integrated genomics; Primary liver cancer

Indexed keywords

EID: 84964744244     PISSN: None     EISSN: 2296634X     Source Type: Journal    
DOI: 10.3389/fcell.2014.00012     Document Type: Article

References (27)

1. American Cancer Society. (2012). Cancer Facts and Figures 2012. Atlanta, GA: American Cancer Society
2. Bard-Chapeau, E. A., Nguyen, A. T., Rust, A. G., Sayadi, A., Lee, P., Chua, B. Q., et al. (2013). Transposon mutagenesis identifies genes driving hepatocellular carcinoma in a chronic hepatitis B mouse model. Nat. Genet. 46, 24-32. doi: 10.1038/ng.2847
3. Budhu, A., Forgues, M., Ye, Q. H., Jia, H. L., He, P., Zanetti, K. A., et al. (2006). Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment. Cancer Cell 10, 99-111. doi: 10.1016/j.ccr.2006.06.016
4. Budhu, A., Roessler, S., Zhao, X., Yu, Z., Forgues, M., Ji, J., et al. (2013). Integrated metabolite and gene expression profiles identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomes. Gastroenterology 144, 1066.e1-1075.e1. doi: 10.1053/j.gastro.2013.01.054
5. Hanahan, D., and Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. Cell 144, 646-674. doi: 10.1016/j.cell.2011.02.013
6. Ji, J., Shi, J., Budhu, A., Yu, Z., Forgues, M., Roessler, S., et al. (2009). MicroRNA expression, survival, and response to interferon in liver cancer. New Engl. J. Med. 361, 1437-1447. doi: 10.1056/NEJMoa0901282
7. Kim, S. M., Leem, S. H., Chu, I. S., Park, Y. Y., Kim, S. C., Kim, S. B., et al. (2012). Sixty-five gene-based risk score classifier predicts overall survival in hepatocellular carcinoma. Hepatology 55, 1443-1452. doi: 10.1002/hep.24813
8. Kumar, M., Zhao, X., and Wang, X. W. (2011). Molecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: one step closer to personalized medicine? Cell Biosci. 1:5. doi: 10.1186/2045-3701-1-5
9. Lawrence, M. S., Stojanov, P., Mermel, C. H., Robinson, J. T., Garraway, L. A., Golub, T. R., et al. (2014). Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 505, 495-501. doi: 10.1038/nature12912
10. Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., et al. (2013). Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499, 214-218. doi: 10.1038/nature12213
11. Lee, J. S., Chu, I. S., Mikaelyan, A., Calvisi, D. F., Heo, J., Reddy, J. K., et al. (2004). Application of comparative functional genomics to identify best-fit mouse models to study human cancer. Nat. Genet 36, 1306-1311. doi: 10.1038/ng1481
12. Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J. F., et al. (2008). Sorafenib in advanced hepatocellular carcinoma. New Engl. J. Med. 359, 378-390. doi: 10.1056/NEJMoa0708857
13. Massague, J. (2007). Sorting out breast-cancer gene signatures. New Engl. J. Med. 356, 294-297. doi: 10.1056/NEJMe068292
14. Nguyen, L. V., Vanner, R., Dirks, P., and Eaves, C. J. (2012). Cancer stem cells: an evolving concept. Nat. Rev. Cancer 12, 133-143. doi: 10.1038/nrc3184
15. Oishi, N., Kumar, M. R., Roessler, S., Ji, J., Forgues, M., Budhu, A., et al. (2012). Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma. Hepatology 56, 1792-1803. doi: 10.1002/hep.25890
16. Ozdemir, B., Abd-Almageed, W., Roessler, S., and Wang, X. W. (2013). iSubgraph: integrative genomics for subgroup discovery in hepatocellular carcinoma using graph mining and mixture models. PLoS ONE 8:e78624. doi: 10.1371/journal.pone.0078624
17. Roessler, S., Budhu, A., and Wang, X. W. (2007). Future of molecular profiling of human hepatocellular carcinoma. Future Oncol. 3, 429-439. doi: 10.2217/14796694.3.4.429
18. Roessler, S., Jia, H. L., Budhu, A., Forgues, M., Ye, Q. H., Lee, J. S., et al. (2010). A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. Cancer Res. 70, 10202-10212. doi: 10.1158/0008-5472.CAN-10-2607
19. Roessler, S., Long, E. L., Budhu, A., Chen, Y., Zhao, X., Ji, J., et al. (2012). Integrative genomic identification of genes on 8p associated with hepatocellular carcinoma progression and patient survival. Gastroenterology 142, 957.e12-966.e12. doi: 10.1053/j.gastro.2011.12.039
20. Shen, H., and Laird, P. W. (2013). Interplay between the cancer genome and epigenome. Cell 153, 38-55. doi: 10.1016/j.cell.2013.03.008
21. Stephens, P. J., Tarpey, P. S., Davies, H., Van Loo, P., Greenman, C., Wedge, D. C., et al. (2012). The landscape of cancer genes and mutational processes in breast cancer. Nature 486, 400-404. doi: 10.1038/nature11017
22. Takano, T., Ohe, Y., Sakamoto, H., Tsuta, K., Matsuno, Y., Tateishi, U., et al. (2005). Epidermal growth factor receptor gene mutations and increased copy numbers predict gefitinib sensitivity in patients with recurrent non-small-cell lung cancer. J. Clin. Oncol. 23, 6829-6837. doi: 10.1200/JCO.2005.01.0793
23. The Cancer Genome Atlas Research Network, Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R., Ozenberger, B. A., et al. (2013). The Cancer Genome Atlas Pan-Cancer analysis project. Nat. Genet. 45, 1113-1120. doi: 10.1038/ng.2764
24. Woo, H. G., Wang, X. W., Budhu, A., Kim, Y. H., Kwon, S. M., Tang, Z. Y., et al. (2011). Association of TP53 mutations with stem cell-like gene expression and survival of patients with hepatocellular carcinoma. Gastroenterology 140, 1063-1070. doi: 10.1053/j.gastro.2010.11.034
25. Yamashita, T., Ji, J., Budhu, A., Forgues, M., Yang, W., Wang, H. Y., et al. (2009). Wang, EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology 136, 1012-1024. doi: 10.1053/j.gastro.2008.12.004
26. Ye, Q. H., Qin, L. X., Forgues, M., He, P., Kim, J. W., Peng, A. C., et al. (2003). Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat. Med. 9, 416-423. doi: 10.1038/nm843
27. Zender, L., Xue, W., Zuber, J., Semighini, C. P., Krasnitz, A., Ma, B., et al. (2008). An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer. Cell 135, 852-864. doi: 10.1016/j.cell.2008.09.061